Drug Trial Radar · NCT07837973
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Last checked: Nov 19, 2026Latest source record: Oct 26, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
220
Planned (sponsor's estimate)
Start
Aug 10, 2026
Primary completion
Aug 24, 2027
Study completion Aug 24, 2027
Sponsor
- Lead sponsor
- Alveus Therapeutics, Inc.Industry
- Sponsor type
- Industry
- First posted
- Sep 24, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A study of ALV-100 to assess efficacy, safety and tolerability among participants with overweight or obesity who have previously achieved a body weight reduction of ≥10% while treated with incretin-based therapies.
Conditions
- Overweight , Obesity
- Adults
Interventions
ALV-100Drug
Experimental drug
PlaceboDrug
Volume matched placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Dose response of ALV-100 as assessed by maintenance of weight lossTime frame: 24 weeks
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
University of Alabama - Birmingham
Birmingham, Alabama · Recruiting
DM Clinical Research
Sun City, Arizona · Recruiting
AMR Clinical
Tempe, Arizona · Recruiting
Profound Research
Oceanside, California · Recruiting
DM Clinical Research
Bradenton, Florida · Recruiting
DM Clinical Research
Doral, Florida · Recruiting
Clinical Neuroscience Solutions
Orlando, Florida · Recruiting
North Georgia Clinical Research
Woodstock, Georgia · Recruiting
Christie Clinic
Champaign, Illinois · Recruiting
BRCR Global Louisiana
Gretna, Louisiana · Recruiting
Profound Research
Farmington Hills, Michigan · Recruiting
ALSA Research-Manhattan
New York, New York · Recruiting
TMA Headlands
Wilmington, North Carolina · Recruiting
Lynn Health Science Institute
Oklahoma City, Oklahoma · Recruiting
AMR Clinical
Nashville, Tennessee · Recruiting
DM Clinical Research
Irving, Texas · Recruiting
DM Clinical Research - Dominion Family Healthcare
San Antonio, Texas · Recruiting
Tekton Research
San Antonio, Texas · Recruiting
DM Clinical Research
Tomball, Texas · Recruiting
AMR Clinical
South Jordan, Utah · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.